| Serial Number | 99222134 |
| Word Mark | ANTHARIS THERAPEUTICS |
| Filing Date | Friday, June 6, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, February 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Custom manufacturing of therapeutic agents, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and engineered antibodies, all for use in pharmaceuticals |
| Goods and Services | Biologics in the nature of pharmaceutical preparations for immunotherapy against cancer; Pharmaceutical and biological preparations for use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells |
| Goods and Services | Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology |
| Description of Mark | The mark consists of an abstract design comprised of two intersecting curved lines, with a star at the intersection of the lines on the left side, positioned before the text ANTHARIS THERAPEUTICS on two lines. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 6, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 6, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 6, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Antharis Therapeutics Holdings Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vista, NY 92081 |
| Event Date | Event Description |
| Friday, June 6, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 6, 2025 | NEW APPLICATION ENTERED |
| Monday, October 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 13, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, October 28, 2025 | ASSIGNED TO EXAMINER |
| Monday, November 3, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, November 3, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, November 3, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 3, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 3, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 3, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |